Search Result "primary myelofibrosis"


Current and Emerging Therapies in Primary Myelofibrosis

Journal: Cardiovascular & Hematological Disorders-Drug Targets
Volume: 12 Issue: 1 Year: 2012 Page: 6-20
Author(s): Sabarish Ayyappan,Murali Janakiram,Radha Raghupathy

JAK2 Inhibitors for Myelofibrosis: Why are They Effective in Patients with and Without JAK2V617F Mutation?

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 12 Issue: 9 Year: 2012 Page: 1098-1109
Author(s): Fabio P. S. Santos,Srdan Verstovsek

Biology and Clinical Management of Myeloproliferative Neoplasms and Development of the JAK Inhibitor Ruxolitinib

Journal: Current Medicinal Chemistry
Volume: 19 Issue: 2 Year: 2012 Page: 4399-4413
Author(s): J. Mascarenhas, T. I. Mughal, S. Verstovsek

Chronic Myelogenous Leukemia

Journal: Current Cancer Therapy Reviews
Volume: 8 Issue: 1 Year: 2012 Page: 3-13
Author(s): Robert P. Hasserjian

Myeloid and Lymphoid Neoplasms with Eosinophilia and Abnormalities of PDGFRA, PDGFRB or FGFR1

Journal: Current Cancer Therapy Reviews
Volume: 8 Issue: 1 Year: 2012 Page: 44-51
Author(s): Cherie H. Dunphy

Myelodysplastic/Myeloproliferative Neoplasms

Journal: Current Cancer Therapy Reviews
Volume: 8 Issue: 1 Year: 2012 Page: 52-65
Author(s): Cherie H. Dunphy

World Health Organization Classification of Myelodysplastic Syndromes

Journal: Current Pharmaceutical Design
Volume: 18 Issue: 22 Year: 2012 Page: 3149-3162
Author(s): Magdalena Czader,Attilio Orazi

Protein Degradation by the Ubiquitin-Proteasome Pathway and Organ Fibrosis

Journal: Current Medicinal Chemistry
Volume: 19 Issue: 6 Year: 2012 Page: 893-900
Author(s): H. Fukasawa, Y. Fujigaki, T. Yamamoto, A. Hishida, M. Kitagawa

Previous   Next

Go To   Results 1 - 1 of 14

Filter Result

Volume Year
Content Type
Ads
© 2024 Bentham Science Publishers | Privacy Policy